PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Orphan Drug

Orphan drug designation, exclusivity, rare-disease launch planning, payer evidence needs, and access implications.

1 article·Lives underApprovals Policy·Last updated 2026-06-21

Biosimilars· June 21, 2026 · 6 min read

Soliris NMOSD Exclusivity Expiration: Skinny Label & REMS Barriers for Bkemv

By Ran Chen#Biosimilars #Interchangeability #Payer Criteria